Sign In
Buy GTHX
$7.15
+0 (+0%)
At Close: Dec 16, 2024
MeiraGTx Holdings PLC (MGTX) Stock Jumps 6.5%: Will It Continue to Soar?
10:46am, Wednesday, 30'th Mar 2022 Zacks Investment Research
MeiraGTx Holdings PLC (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strengt
G1 Therapeutics reports inducement grants
10:49pm, Tuesday, 01'st Mar 2022 Seeking Alpha
G1 Therapeutics (GTHX) granted stock options exercisable for a total 10.8K common shares and an aggregate of 8.8K restricted stock units (RSUs) to four employeesThe options were…
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10:00pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exer
G1 Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference and the 34th Annual Roth 2022 Conference
04:15pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two u
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
01:01pm, Thursday, 24'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Adagio Appoints COO David Hering As Interim CEO
Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced th
G1 Therapeutics'' (GTHX) CEO Jack Bailey on Q4 2021 Results - Earnings Call Transcript
07:22pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
G1 Therapeutics, Inc. (GTHX) Q4 2021 Earnings Call Transcript
06:30pm, Wednesday, 23'rd Feb 2022 The Motley Fool
GTHX earnings call for the period ending December 31, 2021.
G1 Therapeutics, Inc. (GTHX) Q4 2021 Earnings Call Transcript
06:30pm, Wednesday, 23'rd Feb 2022 The Motley Fool
GTHX earnings call for the period ending December 31, 2021.
G1 Therapeutics' (GTHX) CEO Jack Bailey on Q4 2021 Results - Earnings Call Transcript
02:22pm, Wednesday, 23'rd Feb 2022
G1 Therapeutics' (GTHX) CEO Jack Bailey on Q4 2021 Results - Earnings Call Transcript
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
12:45pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
G1 Therapeutics (GTHX) delivered earnings and revenue surprises of 8.74% and 6.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
G1 Therapeutics GAAP EPS of -$0.94 beats by $0.09, revenue of $5.79M beats by $0.07M
11:34am, Wednesday, 23'rd Feb 2022 Seeking Alpha
G1 Therapeutics press release (GTHX): Q4 GAAP EPS of -$0.94 beats by $0.09.Revenue of $5.79M (-65.0% Y/Y) beats by $0.07M.Shares +3.63% PM.As of December 31, 2021, cash and
G1 Therapeutics Provides Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
11:30am, Wednesday, 23'rd Feb 2022 GlobeNewswire Inc.
- Achieved $5.8 Million in Total Revenue in the Fourth Quarter of 2021, Including $4.4 Million in Net Revenue from Sales of COSELA™ (trilaciclib) -
G1 Therapeutics Provides Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
11:30am, Wednesday, 23'rd Feb 2022 GlobeNewswire
- Achieved $5.8 Million in Total Revenue in the Fourth Quarter of 2021, Including $4.4 Million in Net Revenue from Sales of COSELA (trilaciclib) -
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
09:13am, Wednesday, 23'rd Feb 2022
G1 Therapeutics (GTHX) delivered earnings and revenue surprises of 8.74% and 6.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
G1 Therapeutics Q4 2021 Earnings Preview
04:24pm, Tuesday, 22'nd Feb 2022 Seeking Alpha
G1 Therapeutics (NASDAQ:GTHX) is scheduled to announce Q4 earnings results on Wednesday, February 23rd, before market open.The consensus EPS Estimate is -$1.02 (-52.2% Y/Y) and
